STM publisher Elsevier, Netherlands, and the Federation of Biochemical Societies (FEBS) have announced the launch of FEBS Open Bio, an open access journal. The journal will publish articles across the molecular and cellular life sciences in both health and disease.
In launching this new journal, FEBS and Elsevier serve authors who have an interest in a fast publishing process. The journal is open to direct submissions of novel findings. It is also open to the transfer of articles submitted to existing FEBS publications - FEBS Letters, FEBS Journal and Molecular Oncology - which have been judged as sound and a contribution to knowledge, but do not meet the criteria set by the editors for publication in these journals. These manuscripts can now proceed for publication in FEBS Open Bio with their original reviewer reports, without the need to resubmit or reformat the manuscript.
The editorial board of FEBS Open Bio welcomes submissions. All articles are freely available on SciVerse ScienceDirect.
Search for more open access journals
To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.
